Cisplatin resistance-related multi-omics differences and the establishment of machine learning model...
Cisplatin resistance-related multi-omics differences and the establishment of machine learning models
About this item
Full title
Author / Creator
Sui, Qihai , Chen, Zhencong , Hu, Zhengyang , Huang, Yiwei , Liang, Jiaqi , Bi, Guoshu , Bian, Yunyi , Zhao, Mengnan , Zhan, Cheng , Lin, Zongwu , Wang, Qun and Tan, Lijie
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Platinum-based chemotherapies are currently the first-line treatment of non-small cell lung cancer. This study will improve our understanding of the causes of resistance to cisplatin, especially in lung adenocarcinoma (LUAD) and provide a reference for therapeutic decisions in clinical practice.
Cancer Cell Line Encyclopedia (CCLE), The Cancer G...
Alternative Titles
Full title
Cisplatin resistance-related multi-omics differences and the establishment of machine learning models
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4e8e23c938f34aeba4e3a85d97ebfe43
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e8e23c938f34aeba4e3a85d97ebfe43
Other Identifiers
ISSN
1479-5876
E-ISSN
1479-5876
DOI
10.1186/s12967-022-03372-0
